Lanzetta G - Search Results

1

Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study.

Buonerba C, Di Lorenzo G, Pond G, Cartenì G, Scagliarini S, Rozzi A, Quevedo FJ, Dorff T, Nappi L, Lanzetta G, Pagliaro L, Eigl BJ, Naik G, Ferro M, Galdiero M, De Placido S, Sonpavde G. Buonerba C, et al. Among authors: lanzetta g. Front Pharmacol. 2016 Dec 20;7:487. doi: 10.3389/fphar.2016.00487. eCollection 2016. Front Pharmacol. 2016. PMID: 28066240 Free PMC article.

2

Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.

Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A. Lanzetta G, et al. Anticancer Res. 2003 Nov-Dec;23(6D):5159-64. Anticancer Res. 2003. PMID: 14981983 Clinical Trial.

3

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study.

Rozzi A, Nardoni C, Corona M, Restuccia MR, Fabi A, Bria E, Minniti G, Lanzetta G. Rozzi A, et al. Among authors: lanzetta g. Support Care Cancer. 2011 May;19(5):697-701. doi: 10.1007/s00520-010-0893-y. Epub 2010 May 14. Support Care Cancer. 2011. PMID: 20467757 Clinical Trial.

4

Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.

Rozzi A, Salerno M, Bordin F, De Marco F, Di Nicola S, Lanzetta G. Rozzi A, et al. Among authors: lanzetta g. Med Oncol. 2011 Dec;28 Suppl 1:S426-32. doi: 10.1007/s12032-010-9749-z. Epub 2010 Nov 30. Med Oncol. 2011. PMID: 21116878 Clinical Trial.

5

Weekly regimen of paclitaxel and carboplatin as first-line chemotherapy in elderly patients with stage IIIB-IV non small cell lung cancer (NSCLC): results of a phase II study.

Rozzi A, Nardoni C, Corona M, Restuccia MR, Falbo T, Lanzetta G. Rozzi A, et al. Among authors: lanzetta g. J Chemother. 2010 Dec;22(6):419-23. doi: 10.1179/joc.2010.22.6.419. J Chemother. 2010. PMID: 21303751 Clinical Trial.

6

[Pain assessment in terminally-ill cancer patients on admission in hospice and its modification after the first three days of care. A monocentric experience].

Rozzi A, Scirocchi R, Fava A, Bordin F, D'Addario ME, Ranucci A, Lanzetta G, Di Miele D, Ferraccioli A, Terzoli L, Salerno M. Rozzi A, et al. Among authors: lanzetta g. Clin Ter. 2011;162(5):413-7. Clin Ter. 2011. PMID: 22041795 Italian.

7

Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer.

Bossi P, Kornek G, Lanzetta G, Rozzi A, Füreder T, Locati L, Licitra L. Bossi P, et al. Among authors: lanzetta g. Head Neck. 2013 Oct;35(10):1471-4. doi: 10.1002/hed.23170. Epub 2012 Oct 6. Head Neck. 2013. PMID: 23042567

8

Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.

Rozzi A, Santini D, Salerno M, Bordin F, Mancuso A, Minniti G, Nardoni C, Corona M, Falbo PT, Recine F, Lanzetta G. Rozzi A, et al. Among authors: lanzetta g. Med Oncol. 2013 Mar;30(1):407. doi: 10.1007/s12032-012-0407-5. Epub 2013 Jan 10. Med Oncol. 2013. PMID: 23307245 Clinical Trial.

9

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey.

Santini D, Procopio G, Porta C, Ibrahim T, Barni S, Mazzara C, Fontana A, Berruti A, Berardi R, Vincenzi B, Ortega C, Ottaviani D, Carteni G, Lanzetta G, Virzì V, Santoni M, Silvestris N, Satolli MA, Collovà E, Russo A, Badalamenti G, Fedeli SL, Tanca FM, Adamo V, Maiello E, Sabbatini R, Felici A, Cinieri S, Tonini G, Bracarda S. Santini D, et al. Among authors: lanzetta g. PLoS One. 2013 Dec 30;8(12):e83026. doi: 10.1371/journal.pone.0083026. eCollection 2013. PLoS One. 2013. PMID: 24386138 Free PMC article.

10

Editorial Comment to Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.

Rozzi A, Lanzetta G. Rozzi A, et al. Among authors: lanzetta g. Int J Urol. 2015 Oct;22(10):915. doi: 10.1111/iju.12870. Epub 2015 Jul 7. Int J Urol. 2015. PMID: 26153730 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters